Halozyme to Report Third Quarter 2026 Financial and Operating Results
SAN DIEGO, Oct. 22, 2026 /PRNewswire/ -- Halozyme Therapeutics, Inc. (Nasdaq: HALO) ("Halozyme") today announced it will release its third quarter 2026 financial and operating results on Thursday, November 5, 2026, following the close of trading. Halozyme will host a conference call on...
Covered in this story
Call it yourself
No calls on $HALO yet. A scorecard is a price target with a date and the working behind it — tracked, settled and scored in public.
Make the first call on Halozyme Therapeutics →Summary aggregated from PR Newswire's public RSS feed. The full reporting belongs to PR Newswire — please read it on their site.